Abstract

BackgroundIn 2010, the World Health Organization revised guidelines to recommend diagnosis of all suspected malaria cases prior to treatment. There has been no systematic assessment of malaria test uptake for pediatric fevers at the population level as countries start implementing guidelines. We examined test use for pediatric fevers in relation to malaria endemicity and treatment-seeking behavior in multiple sub-Saharan African countries in initial years of implementation.Methods and FindingsWe compiled data from national population-based surveys reporting fever prevalence, care-seeking and diagnostic use for children under five years in 13 sub-Saharan African countries in 2009–2011/12 (n = 105,791). Mixed-effects logistic regression models quantified the influence of source of care and malaria endemicity on test use after adjusting for socioeconomic covariates. Results were stratified by malaria endemicity categories: low (PfPR2–10<5%), moderate (PfPR2–10 5–40%), high (PfPR2–10>40%). Among febrile under-fives surveyed, 16.9% (95% CI: 11.8%–21.9%) were tested. Compared to hospitals, febrile children attending non-hospital sources (OR: 0.62, 95% CI: 0.56–0.69) and community health workers (OR: 0.31, 95% CI: 0.23–0.43) were less often tested. Febrile children in high-risk areas had reduced odds of testing compared to low-risk settings (OR: 0.51, 95% CI: 0.42–0.62). Febrile children in least poor households were more often tested than in poorest (OR: 1.63, 95% CI: 1.39–1.91), as were children with better-educated mothers compared to least educated (OR: 1.33, 95% CI: 1.16–1.54).ConclusionsDiagnostic testing of pediatric fevers was low and inequitable at the outset of new guidelines. Greater testing is needed at lower or less formal sources where pediatric fevers are commonly managed, particularly to reach the poorest. Lower test uptake in high-risk settings merits further investigation given potential implications for diagnostic scale-up in these areas. Findings could inform continued implementation of new guidelines to improve access to and equity in point-of-care diagnostics use for pediatric fevers.

Highlights

  • For many years presumptive anti-malarial treatment for febrile children was promoted in malaria-endemic African countries due to lack of diagnostic tools, resulting in widespread malaria overdiagnosis [1], non-rational use of anti-malarial drugs [2], and poor quality treatment of other fever causes [3]

  • Findings could inform continued implementation of new guidelines to improve access to and equity in pointof-care diagnostics use for pediatric fevers

  • In 2010, the World Health Organization (WHO) revised guidelines to recommend diagnosis of all suspected malaria cases before starting treatment based on expert recommendations and increasing availability of malaria rapid diagnostic tests [4]

Read more

Summary

Introduction

For many years presumptive anti-malarial treatment for febrile children was promoted in malaria-endemic African countries due to lack of diagnostic tools, resulting in widespread malaria overdiagnosis [1], non-rational use of anti-malarial drugs [2], and poor quality treatment of other fever causes [3]. By 2010, 37 African countries had a malaria diagnosis policy for all age groups and programs are investing in wide-scale mRDT provision [7] Despite this investment, evidence to date regarding malaria diagnostic test practices in sub-Saharan Africa is largely derived from adherence studies in limited health facility settings [8,9,10,11,12,13,14,15,16,17,18,19,20,21,22], or from qualitative interviews of health workers with limited external validity [23,24,25,26,27]. We examined test use for pediatric fevers in relation to malaria endemicity and treatment-seeking behavior in multiple sub-Saharan African countries in initial years of implementation

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call